In mouse models of melanoma, colon cancer, and breast cancer, Sakuishi et al. found that CD8+ T cells co-expressing PD1+ and TIM3 + CD8+ T accounted for the majority of the total T cell population. This evidence concerns the gene HAVCR2 and melanoma.